InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Kolchinsky Peter, Chief Executive Officer. Officer active across 2 companies, notably Forma Therapeutics Holdings, Inc.. In total, 6 disclosures have been published. The latest transaction was filed on 29 June 2021 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€2m209,100 shares@ €8.40219.1% of flow
Common Stock
SEC:0001104659-21-087618·
€2m209,100 shares@ €8.4029.5% of flow
Common Stock
SEC:0001104659-21-087618:0·
€7m889,218 shares@ €8.38280.9% of flow
Common Stock
SEC:0001104659-21-085291·
€7m889,218 shares@ €8.38240.5% of flow
Common Stock
SEC:0001104659-21-085291:0·
02,750 shares0
Common Stock
SEC:0000899243-21-025088·
02,750 shares0
Common Stock
SEC:0000899243-21-025088:0·
6 of 6 declarations
About Kolchinsky Peter
Peter Kolchinsky is President and CEO at Forma Therapeutics Holdings, Inc. and Therapeutics Acquisition Corp. He is responsible for the strategic and operational direction of these companies, overseeing all activities to ensure growth and profitability. His leadership is essential for the success of the organization.
